Evofem Biosciences is classified as operating in the Medical Laboratories industry, NAICS Code 621511.
Investor Activity
Evofem Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
October 11, 2023
14
100%
$3 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Evofem Biosciences is developing and marketing.
Evofem Biosciences doesn't have any recent trademark applications, indicating Evofem Biosciences is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
WOMEN'S HEALTH INITIATIVE FOR LIBERATION AND SELF DETERMINATION Organizing and conducting of events, meetings, seminars, courses and conferences, in-person and online, in the fields of sexual health, healthcare, behavior, ethics, to increase awareness and knowledge
03/22/2022
WHEN IT COMES TO CONTRACEPTION, LET'S MAKE IT PERSONAL Marketing services, namely, providing an interactive web site featuring information about conception for connecting a network of health care professionals and service providers with patients
03/21/2022
LET'S MAKE IT PERSONAL Marketing services, namely, providing an interactive web site featuring healthcare information for connecting a network of health care professionals and service providers with patients
03/21/2022
See all trademarks and details in the Full Report.
Market Share of Evofem Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Evofem Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Evofem Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Evofem Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.